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PREVALENCE OF COMORBIDITY AND ITS ASSOCIATION WITH DEMOGRAPHIC 
AND CLINICAL CHARACTERISTICS IN PERSONS WEARING A PROSTHESIS 
AFTER A LOWER-LIMB AMPUTATION
Fred A. DE LAAT, MD, PhD1,2, Pieter U. DIJKSTRA, PhD, PT3,4, Gerardus M. ROMMERS, MD, PhD5, Jan H. B. GEERTZEN, 
MD, PhD3, and Leo D. ROORDA, PT, MD, PhD6
From the 1Rehabilitation Centre Leijpark, Libra Rehabilitation Medicine & Audiology, Tilburg, 2Rehabilitation Centre Tolbrug, Jeroen Bosch 
Hospital, ‘s Hertogenbosch, 3Department of Rehabilitation Medicine, and 4Department of Oral and Maxillofacial Surgery, University of 
Groningen, University Medical Centre of Groningen, Groningen, 5Department of Rehabilitation Medicine, Maastricht University Medical 
Center, Maastricht, and 6Amsterdam Rehabilitation Research Centre | Reade, Amsterdam, The Netherlands
Objective: To describe the prevalence of comorbidity 
and its relationship with demographic and clinical 
characteristics in persons wearing a prosthesis after 
lower-limb amputation.
Design: Cross-sectional study.
Subjects/patients: Persons wearing a prosthesis 
after lower-limb amputation (n = 171; mean age 65 
years (standard deviation 12); 72% men) at the end 
of outpatient rehabilitation treatment.
Methods: Comorbidity was assessed with the Func-
tional Comorbidity Index: a list of 18 items addres-
sing the presence of specific comorbid conditions 
impacting on functional status. Comorbidities in 
medical records were assessed independently by 2 
assessors. Associations with demographic and clini-
cal characteristics were analysed using linear or lo-
gistic regression.
Results: The median (interquartile range) number of 
comorbidities was 3 (2; 4). Three or more comor-
bidities were present in 103 of 171 (60%) partici-
pants. Diabetes was present in 71 (41%), cardiac di-
sease in 60 (35%), and lumbago/degenerative disc 
disease in 39 (23%) participants. The prevalence of 
comorbidities was higher in women and those with 
vascular cause of amputation.
Conclusion: There is a high prevalence of comorbi-
dity at the end of outpatient rehabilitation treatment 
in persons wearing a prosthesis after a lower-limb 
amputation, especially in women and those with 
vascular cause of amputation.
Key words: amputation; comorbidity; prosthesis; rehabilita-
tion.
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Comorbidity has been defined as “any distinct ad-ditional clinical entity that has existed or that may 
occur during the clinical course of a patient who has 
the index disease under study” (1). Comorbidity is 
becoming more and more relevant, both for daily clini-
cal practice and research, given the ageing of modern 
societies, the increased survival from diseases and, 
related to this, the increase in so-called chronic diseases 
(2). Related to this, there is increasing interest in the 
impact of comorbidity on study populations (3, 4).
Persons with a lower-limb amputation (LLA) often 
experience comorbidity (5–7) and the presence of co-
morbidity may impact on their mobility (8–10). The 
presence of comorbidity can influence medical care 
during rehabilitation treatment, as well as the length of 
rehabilitation treatment. From a review of the literature 
until 2007 it was concluded that the impact of comor-
bidity on functional outcome, especially mobility, is 
inconsistent (11). More recent literature, however, 
provides evidence that comorbidity does impact on 
mobility (8–10). 
We are aware of 3 studies assessing the prevalence 
of comorbidity as a primary outcome in persons with a 
LLA (5–7). One study included 24, mainly young, per-
sons with a traumatic cause of amputation (5), whereas 
persons seen in daily clinical practice in rehabilitation 
medicine are predominantly elderly with a vascular 
cause of amputation (12). Another study used available 
administrative data only, and did not use data from 
medical records (6). A third study addressed a sample 
of nursing home residents older than 67 years undergo-
ing a LLA (7), of whom only a minority will function 
with a prosthesis. The majority of persons with a LLA 
seen in daily clinical practice in rehabilitation medi-
cine will function with a prosthesis. The studies did 
LAY ABSTRACT
Persons who have undergone an amputation of a leg, 
frequently suffer from other diseases. Because these 
other diseases can influence prosthetic training, es-
pecially exercise therapy, we explored which diseases 
at which frequencies are prevalent at the start of the 
prosthetic training. We found that the prevalence of di-
seases was higher in women and those with an am-
putation caused by vascular disease. The most preva-
lent diseases were, besides vascular disease, diabetes, 
lumbago, and arthritis. Especially women had a higher 
prevalence of arthritis and  anxiety or panic disorders. 
Therefore we recommend to screen for these diseases 
actively in women, because it may be necessary to 
adapt the prosthetic training for these persons.
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630 F. A. de Laat et al.
not clarify in detail how the presence of comorbidity 
was assessed. In addition, the presence of comorbidity 
was not assessed at the end of outpatient rehabilitation 
treatment, which is, in our view, the phase that is the 
most relevant for daily functioning at home. 
To our knowledge, the association of demographic 
and clinical characteristics with prevalence of a wide 
range of specific comorbidities has not yet been studied 
in persons wearing a prosthesis after a LLA at the end 
of their rehabilitation treatment. Elucidating these as-
sociations would enable the specification of patients 
at risk of comorbidities. Moreover, studying these 
associations enables better predictions with respect to 
the number and presence of specific comorbidities in 
patients who differ with respect to age, sex, or type of 
amputation. Finally, studying these associations ena-
bles better comparison of studies that include samples 
of persons after a LLA who differ with respect to 
demographic or clinical characteristics.
The first aim of this study was to assess the preva-
lence of comorbidity in persons wearing a prosthesis 
after a LLA at the end of rehabilitation treatment. The 
second aim was to analyse associations of comorbidity 
with demographic and clinical characteristics.
METHODS
Participants
Participants were persons with a recent LLA who were recrui-
ted at the end of their rehabilitation treatment. The first group 
consisted of patients at the end of their outpatient rehabilitation 
treatment (in some cases this had been preceded by inpatient 
rehabilitation) in the ‘s-Hertogenbosch rehabilitation centre (re-
habilitation centre group). The second group consisted of patients 
directly after discharge from inpatient or outpatient rehabilita-
tion treatment in nursing homes in the ‘s-Hertogenbosch region 
(nursing home group). These 2 groups encompassed all persons 
wearing a prosthesis after a LLA and undergoing rehabilitation 
treatment in this region. Participants had to meet the following 
inclusion criteria: age ≥ 18 years; currently wearing a prosthesis; 
and able to understand and complete questionnaires. The study 
protocol was approved by the Research Ethics Committee of 
the Jeroen Bosch Hospital, ‘s-Hertogenbosch, The Netherlands.
Procedure
Data on comorbidity, and demographic and clinical characte-
ristics were extracted from medical records. The rehabilitation 
centre group received a questionnaire about their mobility from 
the therapists on the second-to-last day of treatment in the reha-
bilitation centre. They were asked to complete the questionnaire 
at home and bring it with them on the final day of treatment. The 
nursing home group received the questionnaire during their first 
follow-up appointment in the rehabilitation centre. They were 
asked to complete the questionnaire at home and return it by post.
Measurements
To measure comorbidity, we used the Functional Comorbidity 
Index (FCI) (13). The FCI consists of a list of 18 items assessing 
the presence of several comorbidities (yes/no). The total score 
is calculated by summing items scored “yes”. The FCI has been 
proven to have a good conceptual framework (13). FCI scores 
correlated (r = 0.54) with the physical function subscale of the 
Short Form-36 Health Survey (13). The FCI is easy to admi-
nister, as only summation regarding the presence or absence 
for 18 diagnoses is required, and thus weighting of diseases is 
not necessary. To obtain the most reliable FCI score, we used a 
method described previously (14): 2 medical doctors (F.A.d.L. 
and an independent medical doctor) studied the protocol for 
scoring instructions of the FCI, studied the medical records and 
then scored the presence of all 18 diagnoses independently. A 
comorbidity was defined as being present if it was described in 
an outgoing medical letter of the medical doctor or if it was co-
ded as such in the (digital) medical records of the rehabilitation 
centre, nursing home or hospital. In case of disagreement, each 
score was discussed until consensus was reached. Appendix 1 
provides an overview of the comorbidities included in the FCI.
Demographic (age, sex) and clinical characteristics (cause, 
level and sidedness of amputation, and setting) were recorded. 
Functional mobility was assessed using 4 self-reported ques-
tionnaires: the Walking Questionnaire (WQ35) (15, 16), the 
Climbing Stairs Questionnaire (CSQ15) (17, 18), the Rising 
and Sitting Down Questionnaire (R&SDQ39) (19–21) and the 
Locomotor Capabilities Index (LCI) (22).
The WQ35 assesses activity limitations in walking. It con-
tains 35 items with dichotomous response options (yes/no). 
The sum score is calculated by adding scores for the 35 items. 
A standardized sum score ranges from 0 to 100, with higher 
scores indicating less limitation in walking (15). The Walking 
Questionnaire had good construct validity and test–retest relia-
bility in persons with a LLA (23).
The CSQ15 assesses activity limitations in climbing stairs. 
It contains 15 items with dichotomous response options. The 
sum score is calculated by adding scores for the 15 items. This 
score is subsequently standardized (range 0–100, with higher 
scores indicating less limitation in climbing stairs). Patients 
can mark a 16th item if they do not climb stairs at all because 
of their health, and these patients are given a score of 0 (17). 
The questionnaire has been tested in persons with a LLA and 
exhibited good construct validity and test–retest reliability (24).
The R&SDQ39 assesses activity limitations in rising and 
sitting down. It contains 39 items with dichotomous response 
options. The standardized sum score is derived from the 1-pa-
rameter logistic model (range 0–100, with higher scores indicat-
ing less limitation). The R&SDQ39 is a unidimensional scale. It 
has good fit with a parametric item response theory model, the 
1-parameter logistic model, good intratest reliability and good 
content validity (19, 20). The R&SDQ39 showed good construct 
validity and test–retest reliability in persons with a LLA (25).
The LCI assesses a range of locomotor activities, such as 
rising from a chair or the floor, walking on a variety of surfaces, 
and climbing stairs and kerbs. It consists of 14 items with 4 
response options: unable (score 0), able if someone helps me 
(score 1), able if someone is near me (score 2), or able alone 
(score 3). The sum scores range from 0 to 42, with higher scores 
indicating more locomotor capabilities (or less limitation). The 
construct validity and the test–retest reliability of the LCI have 
been reported to be good (22).
Data analysis
The total number of comorbidities and the presence of specific 
comorbidities with counts (percentages) was recorded. With the 
comorbidity total score or the presence of specific comorbidities 
www.medicaljournals.se/jrm
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631Comorbidity after a lower-limb amputation
as the outcome, the patient characteristics were analysed univa-
riately for their association, using non-parametric statistics. The 
level of significance was set at p ≤ 0.05. Associated variables 
(p ≤ 0.10) were subsequently entered into a linear regression 
model (total score) and logistic regression models (specific 
comorbidities) as predictors. Through backward stepwise elimi-
nation, the non-contributing variables (p > 0.05) were excluded. 
All statistics were calculated using SPSS 18.0 for Windows 
(SPSS Inc., Chicago, IL, USA).
RESULTS
Patient characteristics
A total of 175 persons with a LLA met the criteria, 
and all participated in the study. Data regarding the 
comorbidity were not available for 2 participants. 
Characteristics of the remaining 173 participants are 
summarized in Table I. The mean age ± standard devia-
tion (SD)) of these participants was 65 years (SD 12) 
and 72% of the participants were men.
Total number of comorbidities
The FCI total score ranged from 0 to 8, with a median 
(IQR) of 3 (2; 4). Of the participants, only 8 (5%) had 
no comorbidities, whereas 103 (60%) had 3 or more 
comorbidities (Table I). In total, 60 persons with a 
LLA (35%) had at least one of the following 3 cardiac 
diagnoses: angina pectoris, congestive heart failure, or 
myocardial infarction.
Table I. Patient characteristics 
Personal characteristics, n (%)
Age
  < 50 years 24 (14)
  50–59 years 40 (23)
  60–69 years 51 (29)
  > 70 years 58 (34)
Sex
  Women 49 (28)
  Men 124 (72)
Clinical characteristics, n (%)
Amputation etiology
  Vascular 142 (82)
  Non-vascular 31 (18)
Amputation level
  Unilateral amputation
      Higher (HD, TF or KD) 66 (38)
      Lower (TT or Syme) 95 (55)
  Bilateral amputation 12 (7)
Setting
  Rehabilitation centre 155 (90)
  Nursing home 18 (10)
Functional characteristics
Walking, median (IQR) 56 (31; 72)
Climbing stairs, median (IQR) 38 (0; 56)
Rising and sitting down, median (IQR) 48 (0; 57)
Locomotor capabilities, median (IQR) 30 (22; 36)
Comorbidities, n (%)
  0 8 (5)
  1 28 (16)
  2 34 (20)
  3 35 (20)
  4 29 (17)
  5 17 (10)
  6 12 (7)
  7 8 (5)
  8 2 (1)
SD: standard deviation; IQR: interquartile range; HD: hip disarticulation; TF 
transfemoral amputation; KD: knee disarticulation; TT: transtibial amputation.
Table II. Prevalence of total number of comorbidities and their associations with patient characteristics
FCI total score
Univariate Multivariate Linear regression
Median (IQR) p-value  β S.E. (95% CI) p-value
All participants
Age p = 0.003*
< 50 years 1 (0; 3)
50–59 years 3 (2; 4)
60–69 years 4 (2; 5)
> 70 years 3 (2; 4.25)
Sex p = 0.007**
Women 4 (2; 5)
Men 3 (2; 4) -0.89 0.37 (-1.62 to -0.15) 0.019
Amputation aetiology p = < 0.001**
Vascular 3 (2; 5) 1.91 0.44  (1.04 to 2.79) < 0.001
Non-vascular 2 (1; 3)
Amputation level
Unilateral amputation p = 0.474**
Higher (HD, TF or KD) 2.5 (2; 4)
Lower (TT or Syme) 3 (2; 4)
Bilateral amputation*** 4 (3; 5)***
Setting p = 0.652**
Rehabilitation centre 3 (2; 4) 
Nursing home 3 (1.75; 5)
Constant 2.11 0.51  (1.11 to 3.12) < 0.001
Significance (2-tailed p) of Pearson chi-square test unless noted otherwise. *Significance (2-tailed p) of Kruskal-Wallis test. *Significance (2-tailed p) of Mann-
Whitney U test. **Not univariately analysed because of the small number of patients. 
CI: Functional Comorbidity Index; IQR: interquartile range; OR: odds ratio; CI: confidence interval; HD: hip disarticulation; TF transfemoral amputation; KD: 
knee disarticulation; TT: transtibial amputation.
J Rehabil Med 50, 2018
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632 F. A. de Laat et al.
• Age was univariately associated with peripheral vas-
cular disease. Multivariate analysis showed that older 
persons had a higher risk of having peripheral vas-
cular disease (independent of cause of amputation), 
and of having rheumatoid arthritis or osteoarthritis.
• Sex was univariately associated with lumbago, rheu-
matoid arthritis or osteoarthritis, angina pectoris, 
body mass index > 30, anxiety or panic disorders, 
and osteoporosis. Multivariate analysis showed that 
females had a higher risk of having lumbago, rheu-
matoid arthritis or osteoarthritis, obesity, or anxiety 
or panic disorders.
• Cause of amputation was univariately associated with 
peripheral vascular disease, diabetes, myocardial 
infarct, angina pectoris, gastrointestinal ulcer, and 
rheumatoid arthritis or osteoarthritis. Multivariate 
analysis showed that persons with vascular cause of 
amputation had a higher risk of having diabetes or 
myocardial infarct, whereas they had a lower risk of 
having rheumatoid arthritis or osteoarthritis.
• Level of amputation was univariately associated with 
peripheral vascular disease and diabetes. Persons 
with a lower level of amputation had a lower risk of 
having peripheral vascular disease.
• Having a bilateral amputation was multivariately 
associated with having diabetes and having obesity.
• Rehabilitation in a nursing home was univariately 
associated with peripheral vascular disease and neu-
rological diseases.
Total number of comorbidities and demographic and 
clinical characteristics
Univariate and multivariate relationships of the to-
tal number of comorbidities with demographic and 
clinical characteristics are summarized in Table II. 
Univariate analysis showed a relationship (p ≤ 0.05) 
with age, sex and amputation aetiology. Multivariate 
analysis showed that women and persons with vascular 
cause of LLA had more comorbidities.
Prevalence of specific comorbidities
The prevalence of The prevalence of the 2 most im-
portant comorbidities is presented in Table III . The 
complete version of Table III with all specific comor-
bidities and their associations is available in Table SI1. 
Besides peripheral vascular disease (83%) and diabetes 
(41%), there was a high prevalence of lumbago (23%) 
and rheumatoid arthritis or osteoarthritis (22%).
Specific comorbidities and demographic and clinical 
characteristics
Univariate and multivariate relationships between spe-
cific comorbidities and demographic and clinical cha-
racteristics are summarized in Table SI1. The following 
univariate and multivariate relationships were found:
Table III. Prevalence of specific comorbidities and their associations with patient characteristics 
 
Peripheral vascular disease Arthritis (rheumatoid or osteoarthritis)
Univariate Multivariate logistic regression Univariate Multivariate logistic regression
n (%) p-value β S.E. OR (95% CI) p-value p (%) p-value β S.E. OR (95% CI) p-value
All participants 144 (83)  38 (22)
Age < 0.001*  0.057*
< 50 years 12 (50)  1 (4)
50–59 years 33 (83) 1.86 0.64 6.45 (1.84 to 22.67) 0.004 11 (28) 3.20 1.17 24.43 (2.45 to 244.13) 0.007
60–69 years 45 (88) 2.45 0.65 11.57 (3.21 to 41.68) < 0.001 9 (18) 2.78 1.19 16.15 (1.57 to 165.76) 0.019
> 70 years 54 (93) 2.95 0.71 19.06 (4.71 to 77.14) < 0.001 17 (30) 3.43 1.17 30.84 (3.13 to 303.76) 0.003
Sex 0.317**  0.011** 
Women 43 (88)  17 (35)
Men 101 (81)  21 (17) -1.32 0.43 0.26 (0.11 to 0.62) 0.002
Amputation aetiology < 0.001**  0.045** 
Vascular 140 (99)  27 (19) -1.86 0.54 0.16 (0.05 to 0.45) < 0.001
Non-vascular 4 (13)  11 (36)
Amputation level 0.011**  0.281** 
Unilateral amputation  
Higher (HD, TF or KD) 48 (73)  18 (27)
Lower (TT or Syme) 84 (88) -1.25 0.48 0.29 (0.11 to 0.73) 0.009 19 (20)
Bilateral amputation***  
Setting 0.044**  0.978** 
Rehabilitation centre 126 (81)  34  (22)
Nursing home 18 (100)  4 (22)
Constant 0.21 0.49 1.24 0.66 -1.84 1.07 0.16 0.084
Significance (2-tailed p) of Pearson chi-square test unless noted otherwise. Significance (2-tailed p) of Kruskal-Wallis test. *Significance (2-tailed p) of Mann-
Whitney U test. **Not univariately analysed because of the small number of patients. 
CI: Functional Comorbidity Index; IQR: interquartile range; OR: odds ratio; CI: confidence interval; HD: hip disarticulation; TF transfemoral amputation; KD: 
knee disarticulation; TT: transtibial amputation. Note: for all specific comorbidities: see the online version of the table.
1http://www.medicaljournals.se/jrm/content/?doi=10.2340/16501977-2336
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633Comorbidity after a lower-limb amputation
DISCUSSION
A high prevalence of comorbidities was found in per-
sons wearing a prosthesis after a LLA, with most of 
them having 3 or more comorbidities. The prevalence 
of comorbidities was higher in women and in those 
with vascular cause of amputation. The most preva-
lent comorbidities (> 20%) were peripheral vascular 
disease, diabetes, lumbago, and rheumatoid arthritis or 
osteoarthritis. The prevalence of these comorbidities 
was related to demographic and clinical characteristics.
The study population was the total number of persons 
from the ‘s-Hertogenbosch region wearing an prosthesis 
after a LLA. The study population is representative of 
the whole of the Netherlands with regard to cause and 
level of amputation (12). In general, in the Netherlands, 
rehabilitation physicians are consulted when hospital-
ized persons have undergone a LLA. Persons will be 
referred to a rehabilitation centre only if the rehabilita-
tion physician predicts that the patient will be able to use 
a prosthesis. For this reason we focused in our study on 
persons wearing a prosthesis. This study population may 
differ from other countries where, for instance, all per-
sons with a LLA are referred to a rehabilitation centre.
There are several instruments for scoring comorbi-
dity, but many of them have primarily been developed 
to predict mortality. The FCI was applied because it 
was developed to predict physical function (13), which, 
in our view, is key to rehabilitation medicine. The 
FCI has been applied, so far, in persons after stroke 
(median FCI score 2, range 0–12) (26) and in critically 
ill patients with acute lung injury (median FCI score 
2, interquartile range 1–3) (27). For future studies we 
recommend validating the application of the FCI in 
patients with a LLA by studying its association with 
the functioning level of persons with a LLA.
Prevalence of comorbidity
Because the prevalence of comorbidity in persons with 
a LLA has so far been assessed using other selection 
criteria, procedures, and instruments, it is difficult to 
compare the current results with previous studies (5, 
6). This concerns the total number of comorbidities 
as well as the prevalence of a specific comorbidity, 
such as diabetes, stroke, or a cardiac disease (8, 28) 
or hemiplegia in persons with a LLA (9). A recent 
study assessed pre-operative comorbidities in patients 
revascularized for critical limb ischaemia. Of this 
population, 19% underwent a LLA within 3 years. 
That study showed similar results concerning the in-
cidence of stroke, diabetes, COPD and having had a 
myocardial infarct. The incidence of angina pectoris 
and heart failure was higher in their study, but they 
showed a substantial mortality after revascularization 
(29). A recent study regarding the incidence of anxi-
ety or depression amongst persons after a LLA, due to 
diabetes, showed even higher incidences of anxiety or 
depression (30). For future research, we recommend 
a standardized description of comorbid conditions in 
studies of persons with a LLA. If the validation stud-
ies of the FCI in patients with LLA yield satisfactory 
results, the FCI might be the measurement instrument 
of first choice enabling a standardized assessment and 
description.
Comorbidities and demographic and clinical 
characteristics
In the current study higher age was associated with 
higher prevalence of rheumatoid or osteoarthritis. The 
higher prevalence of osteoarthritis in persons with a 
LLA has been demonstrated previously, but these stud-
ies addressed persons with a LLA of traumatic origin 
and wearing a prosthesis for a longer time (31, 32). In 
those studies the higher prevalence, compared with 
the general population, was interpreted as the result of 
walking with a prosthesis. This interpretation seems an 
unlikely explanation for our study, where most persons 
had a prosthesis prescribed for the first time. We are 
not aware of studies assessing arthritis in persons with 
a LLA before the prescription of a prosthesis and the 
start of prosthetic training.
Female sex was associated with a higher total 
number of comorbidities and with several specific 
comorbidities, such as lumbago, rheumatoid arthritis 
or osteoarthritis and anxiety or panic disorders. These 
comorbidities can influence the functional outcome of 
prosthetic training. The relationship between female 
sex and poorer outcome has been described previously 
(7). This relationship might, in part, be mediated by 
the higher number of comorbidities.
The relationship between vascular cause of ampu-
tation and comorbid peripheral vascular disease was 
not further analysed in this study because we consider 
both to be exponents of the same underlying disease. 
Surprisingly, non-vascular cause of amputation was 
correlated with a higher prevalence of rheumatoid or 
osteoarthritis. The reason for this is unclear. We are not 
aware of studies addressing this relationship.
Clinical relevance
Comorbidity is one of the factors used to describe the 
health status of a study population. Given the high 
prevalence of comorbidities and the impression that 
medical records are often incomplete (as rehabilitation 
centres do not always have access to the hospital data) 
with respect to comorbidities, we recommend regis-
tering comorbidities at the start of prosthetic training. 
J Rehabil Med 50, 2018
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634 F. A. de Laat et al.
In older persons and females we found a high preva-
lence of rheumatoid arthritis or osteoarthritis. These 
comorbidities may interfere with prosthetic training, 
especially exercise therapy. Therefore we recommend 
actively screening for these comorbidities, especially 
in persons reporting arthralgia. It may be necessary 
to adapt the prosthetic training in order to avoid the 
side-effects of training. It was also found that females, 
in comparison with males, had a higher prevalence of 
anxiety or panic disorders. Therefore we recommend 
actively screening for this comorbidity, because this 
is not always noted in the medical record. It may be 
necessary to adapt the prosthetic training to more 
task- and context-specific training with the principles 
of graded exposure (33).
Knowledge of the relationship between comorbidi-
ties and mobility in persons wearing a prosthesis is 
limited. A recent review, addressing the relationship 
between the presence of hemiplegia and ambulation 
and independence in persons with a LLA and wearing 
a prosthesis (9), showed that hemiplegia resulted in a 
lower rates of successful ambulation and independ-
ence. A recent study found a relationship between the 
total number of comorbidities and perceived limita-
tions in climbing stairs (10). Another recent review 
addressing the relationship between the presence of 
cardiovascular diseases and mobility in persons with a 
LLA (8) showed that cardiovascular diseases were as-
sociated with a smaller chance of becoming a prosthetic 
walker and with poorer mobility outcomes. For future 
research we recommend studying the relationship 
between the most prevalent comorbidities (peripheral 
vascular disease, diabetes, lumbago arthritis) and mo-
bility in persons with a LLA and wearing a prosthesis.
Study limitations
This study has some limitations. First, it assessed only 
the presence of specific comorbidities; the severity 
of these comorbidities was not assessed. Secondly, 
it included only those persons with a LLA who were 
wearing a prosthesis at the end of their treatment. The-
refore, the results cannot be generalized to persons with 
a LLA not wearing a prosthesis. Finally, the FCI has 
been validated in 2 large, multi-site, national, general 
databases (9), but not specifically in persons with a 
LLA. However, as far as we know, none of existing co-
morbidity indices is validated for persons with a LLA.
Conclusion
There is a high prevalence of comorbidities at the 
end of rehabilitation treatment in persons wearing a 
prosthesis after a LLA, especially in women and those 
with vascular cause of amputation. We recommend a 
standardized description of comorbid conditions in 
patients with LLA.
The authors have no conflicts of interest to declare.
REFERENCES
1. Feinstein AR. The pre-therapeutic classification of co-mor-
bidity in chronic disease. J Chronic Dis 1970; 23: 455–468.
2. Barnett K, Mercer SW, Norbury M, Watt G, Wyke S, Guthrie 
B. Epidemiology of multimorbidity and implications for 
health care, research, and medical education: a cross-
sectional study. Lancet 2012; 380: 37–43.
3. van den Akker M, Buntinx F, Metsemakers JF, Roos S, 
Knottnerus JA. Multimorbidity in general practice: pre-
valence, incidence, and determinants of co-occurring 
chronic and recurrent diseases. J Clin Epidemiol 1998; 
51: 367–375.
4. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How 
to measure comorbidity. a critical review of available 
methods. J Clin Epidemiol 2003; 56: 221–229.
5. Melchiorre PJ, Findley T, Boda W. Functional outcome and 
comorbidity indexes in the rehabilitation of the traumatic 
versus the vascular unilateral lower limb amputee. Am J 
Phys Med Rehabil 1996; 75: 9–14.
6. Kurichi JE, Stineman MG, Kwong PL, Bates BE, Reker DM. 
Assessing and using comorbidity measures in elderly 
veterans with lower extremity amputations. Gerontology 
2007; 53: 255–259.
7. Vogel TR, Petroski GF, Kruse RL. Impact of amputation 
level and comorbidities on functional status of nursing 
home residents after lower extremity amputation. J Vasc 
Surg 2014; 59: 1323–1330.
8. Kaptein S, Geertzen JHB, Dijkstra PU. Association between 
cardiovascular diseases and mobility in persons with lower 
limb amputation: a systematic review. Disabil Rehabil 
2018; 40: 883–888.
9. Hebert JS, Payne MW, Wolfe DL, Deathe AB, Devlin M. 
Comorbidities in amputation: a systematic review of 
hemiplegia and lower limb amputation. Disabil Rehabil 
2012; 34: 1943–1949.
10. de Laat FA, Rommers GM, Dijkstra PU, Geertzen JH, Ro-
orda LD. Climbing stairs after outpatient rehabilitation for 
a lower-limb amputation. Arch Phys Med Rehabil 2013; 
94: 1573–1579.
11. Sansam K, Neumann V, O’Connor R, Bhakta B. Predicting 
walking ability following lower limb amputation: a syste-
matic review of the literature. J Rehabil Med 2009; 41: 
593–603.
12. Fortington LV, Rommers GM, Postema K, van Netten 
JJ, Geertzen JH, Dijkstra PU. Lower limb amputation 
in Northern Netherlands: unchanged incidence from 
1991–1992 to 2003–2004. Prosthet Orthot Int 2013; 37: 
305–310.
13. Groll DL, To T, Bombardier C, Wright JG. The development 
of a comorbidity index with physical function as the out-
come. J Clin Epidemiol 2005; 58: 595–602.
14. Fortin M, Hudon C, Dubois MF, Almirall J, Lapointe L, Soubhi 
H. Comparative assessment of three different indices of 
multimorbidity for studies on health-related quality of life. 
Health Qual Life Outcomes 2005; 3: 74.
15. Roorda LD, Roebroeck ME, van Tilburg T, Molenaar IW, 
Lankhorst GJ, Bouter LM, et al. Measuring activity limita-
tions in walking: development of a hierarchical scale for 
patients with lower-extremity disorders who live at home. 
Arch Phys Med Rehabil 2005; 86: 2277–2283.
16. Roorda LD. Measurement instruments [cited 2017 Oct 
10]. Available from: https://www.leo-d-roorda.nl/walking-
questionnaire-wq35/.
17. Roorda LD, Roebroeck ME, van Tilburg T, Lankhorst GJ, 
Bouter LM. Measuring activity limitations in climbing 
www.medicaljournals.se/jrm
JR
M
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
JR
M
Jo
ur
na
l o
f 
R
eh
ab
ili
ta
ti
on
 M
ed
ic
in
e
635Comorbidity after a lower-limb amputation
stairs: development of a hierarchical scale for patients 
with lower-extremity disorders living at home. Arch Phys 
Med Rehabil 2004; 85: 967–971.
18. Roorda LD. Measurement instruments [cited 2017 Oct 10]. 
Available from: https://www.leo-d-roorda.nl/climbing-
stairs-questionnaire-csq15/.
19. Roorda LD, Roebroeck ME, Lankhorst GJ, van Tilburg T, 
Bouter LM. Measuring functional limitations in rising and 
sitting down: development of a questionnaire. Arch Phys 
Med Rehabil 1996; 77: 663–669.
20. Roorda LD, Molenaar IW, Lankhorst GJ, Bouter LM. Impro-
vement of a questionnaire measuring activity limitations 
in rising and sitting down in patients with lower-extremity 
disorders living at home. Arch Phys Med Rehabil 2005; 
86: 2204–2210.
21. Roorda LD. Measurement instruments [cited 2017 Oct 10]. 
Available from: https://www.leo-d-roorda.nl/rising-and-
sitting-down-questionnaire-rsdq39/.
22. Gauthier-Gagnon C, Grise MC. Prosthetic profile of the 
amputee questionnaire: validity and reliability. Arch Phys 
Med Rehabil 1994; 75: 1309–1314.
23. de Laat FA, Rommers GM, Geertzen JH, Roorda LD. Con-
struct validity and test-retest reliability of the walking 
questionnaire in people with a lower limb amputation. 
Arch Phys Med Rehabil 2012; 93: 983–989.
24. de Laat FA, Rommers GM, Geertzen JH, Roorda LD. Con-
struct validity and test-retest reliability of the climbing 
stairs questionnaire in lower-limb amputees. Arch Phys 
Med Rehabil 2010; 91: 1396–1401.
25. de Laat FA, Rommers GM, Geertzen JH, Roorda LD. Con-
struct validity and test-retest reliability of the questionn-
aire rising and sitting down in lower-limb amputees. Arch 
Phys Med Rehabil 2011; 92: 1305–1310.
26. Tessier A, Finch L, Daskalopoulou SS, Mayo NE. Validation 
of the Charlson Comorbidity Index for predicting functio-
nal outcome of stroke. Arch Phys Med Rehabil 2008; 89: 
1276–1283.
27. Fan E, Gifford JM, Chandolu S, Colantuoni E, Pronovost PJ, 
Needham DM. The functional comorbidity index had high 
inter-rater reliability in patients with acute lung injury. 
BMC Anesthesiol 2012; 12: 21.
28. Fortington LV, Geertzen JH, van Netten JJ, Postema K, 
Rommers GM, Dijkstra PU. Short and long term mortality 
rates after a lower limb amputation. Eur J Vasc Endovasc 
Surg 2013; 46: 124–131.
29. Baubeta Fridh E, Andersson M, Thuresson M, Sigvant B, 
Kragsterman B, Johansson S, et al. Amputation rates, 
mortality, and pre-operative comorbidities in patients 
revascularised for intermittent claudication or critical limb 
ischaemia: a population based study. Eur J Vasc Endovasc 
Surg 2017; 54: 480–486.
30. Pedras S, Carvalho R, Pereira MG. A predictive model of 
anxiety and depression symptoms after a lower limb am-
putation. Disabil Health J 2018; 11: 79–85.
31. Struyf PA, van Heugten CM, Hitters MW, Smeets RJ. The 
prevalence of osteoarthritis of the intact hip and knee 
among traumatic leg amputees. Arch Phys Med Rehabil 
2009; 90: 440–446.
32. Gailey R, Allen K, Castles J, Kucharik J, Roeder M. Review 
of secondary physical conditions associated with lower-
limb amputation and long-term prosthesis use. J Rehabil 
Res Dev 2008; 45: 15–29.
33. van Twillert S, Postema K, Geertzen JH, Hemminga T, 
Lettinga AT. Improving rehabilitation treatment in a local 
setting: a case study of prosthetic rehabilitation. Clin 
Rehabil 2009; 23: 938–947.
Appendix 1. The Functional Comorbidity Index
1. Arthritis (rheumatoid and osteoarthritis)
2. Osteoporosis
3. Asthma
4. Chronic obstructive pulmonary disease (COPD), or emphysema
5. Angina pectoris
6. Congestive heart failure
7. Myocardial infarct
8. Neurological disease (such as multiple sclerosis or Parkinson’s disease)
9. Stroke or transient ischaemic attack (TIA)
10. Peripheral vascular disease
11. Diabetes mellitus
12. Upper gastrointestinal disease (ulcer, hernia, reflux)
13. Depression
14. Anxiety or panic disorders
15. Visual impairment
16. Hearing impairment (even with hearing aids)
17. Low back pain
18. Obesity and/or body mass index > 30
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